Rolistobart
Rolistobart is a humanized immunoglobulin G4-kappa, anti-LILRB4/CD85k monoclonal antibody. Rolistobart is an immunostimulant and antineoplastic[1].
Product Specifications
CAS Number
[2723442-10-0]
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rolistobart.html
Purity
97.78
Solubility
10 mM in DMSO
Smiles
[Rolistobart]
Molecular Weight
(146.62 kDa)
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 36, No. 4, 2022.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
RM-D160722-01 10 mg
Dapagliflozin Impurity POE (hydroperoxy impurity)
Sign In for Pricing
View Details 
RM-D160722-02 25 mg
Dapagliflozin Impurity POE (hydroperoxy impurity)
Sign In for Pricing
View Details RM-D160722-03 50 mg
Dapagliflozin Impurity POE (hydroperoxy impurity)
Sign In for Pricing
View Details 
RM-D160722-04 100 mg
Dapagliflozin Impurity POE (hydroperoxy impurity)
Sign In for Pricing
View Details MET-C52H9-100ug 100 µg
Cynomolgus HGF R / c-MET Protein, His Tag (MALS verified)
Sign In for Pricing
View Details K2427207 1.0 µg DNA
TP53TG5 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details